(Q33544517)

27 July 2017

title

Receptor imaging in the diagnosis and treatment of pituitary tumors. (English)

1 reference

27 July 2017

3

Krenning EP

1 reference

27 July 2017

1

Kwekkeboom DJ

1 reference

27 July 2017

2

de Herder WW

1 reference

27 July 2017

publication date

1 January 1999

1 reference

Journal of Endocrinological Investigation

27 July 2017

published in

1 reference

27 July 2017

volume

22

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

80-88

1 reference

Modern imaging of the pituitary

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Distinction of masses involving the sella and suprasellar space: specificity of imaging features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Pituitary imaging using a labelled somatostatin analogue in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

111Indium-pentetreotide pituitary scintigraphy and hormonal responses to octreotide in acromegalic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to ocreotide therapy and do not correlate with tumor histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Somatostatin receptor imaging in non-functioning pituitary adenomas: value of an uptake index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Gonadotrophin and alpha subunit secretion by human 'functionless' pituitary adenomas in cell culture: long term effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Gonadotroph cell adenomas of the pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Confounding factors in the interpretation of gonadotropin and gonadotropin-subunit release from cultured human pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Discordant serum alpha-subunit and FSH concentrations in a woman with a pituitary tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

The effect of dopamine agonist therapy on large functionless pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Bromocriptine therapy for "nonfunctioning" pituitary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Size reduction of extrasellar pituitary tumors during bromocriptine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

Gonadotropin Secretion in Vitro by Human Pituitary Null Cell Adenomas and Oncocytomas**

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345484

In VivoDetection of Somatostatin Receptors in Patients with Functionless Pituitary Adenomas by Means of a Radioiodinated Analog of Somatostatin ([123I]SDZ 204–090)*

21 January 2018

1 reference

12 December 2020

[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas

1 reference

12 December 2020

Long-term treatment with the dopamine agonist CV 205-502 of patients with a clinically non-functioning, gonadotroph, or alpha-subunit secreting pituitary adenoma

1 reference

12 December 2020

Quantitative Electron Microscopic Autoradiography of Insulin, Glucagon, and Somatostatin Binding Sites on Islets

1 reference

12 December 2020

Dopaminergic regulation of alpha-subunit secretion and messenger ribonucleic acid levels in alpha-secreting pituitary tumors

1 reference

12 December 2020

Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy

1 reference

12 December 2020

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide

1 reference

12 December 2020

Dopamine agonists and pituitary tumor shrinkage

1 reference

12 December 2020

Clinical relevance of somatostatin receptor scintigraphy in patients with skull base tumours

1 reference

12 December 2020

3HSpiperone Binding to Human Anterior Pituitaries and Pituitary Adenomas Secreting Prolactin, Growth Hormone, and Adrenocorticotropic Hormone*

1 reference

12 December 2020

Secretion of LH, FSH, and PRL shown by cell culture and immunocytochemistry of human functionless pituitary adenomas

1 reference

12 December 2020

Demonstration of specific dopamine receptors on human pituitary adenomas

1 reference

12 December 2020

Rapid improvement in visual field defects following bromocriptine treatment of patients with non-functioning pituitary adenomas

1 reference

12 December 2020

Extrapituitary acromegaly

1 reference

12 December 2020

Dopaminergic binding sites in human pituitary adenomas other than prolactinomas

1 reference

12 December 2020

Bromocriptine therapy as pre-operative adjunct of non-functional pituitary macroadenomas

1 reference

12 December 2020

Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy

1 reference

12 December 2020

Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly

1 reference

12 December 2020

Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging

1 reference

12 December 2020

Bromocriptine therapy for non-functioning pituitary adenoma

1 reference

12 December 2020

Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas

1 reference

12 December 2020

Combined use of 111In-labeled pentetreotide and three-step immunoscintigraphy with antichromogranin A monoclonal antibody in the diagnosis of pituitary adenomas

1 reference

12 December 2020

Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy

1 reference

12 December 2020

Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide

1 reference

12 December 2020

Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels

1 reference

12 December 2020

Indium-111-DTPA-octreotide uptake measured in normal and abnormal pituitary glands.

1 reference

12 December 2020

Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies

1 reference

12 December 2020

Scintigraphic assessment of pituitary adenomas and several diseases by indium-111-pentetreotide

1 reference

12 December 2020

Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine

1 reference

12 December 2020

Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture

1 reference

12 December 2020

Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas

1 reference

12 December 2020

The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro

1 reference

12 December 2020

Treatment of acromegaly with dopamine agonists

1 reference

12 December 2020

Bromocriptine increasingly suppresses the in vitro gonadotropin and alpha-subunit release from pituitary adenomas during long term culture

1 reference

12 December 2020

Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.

1 reference

12 December 2020

Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro

1 reference

12 December 2020

Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas

1 reference

12 December 2020

Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor

1 reference

12 December 2020

Bromocriptine in management of large pituitary tumours

1 reference

12 December 2020

Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors

1 reference

12 December 2020

Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345484

1 reference

Dimensions Publication ID

27 July 2017

1018854121

0 references

1 reference